Biotoxtech Co. Ltd (086040) - Net Assets

Latest as of March 2026: ₩29.25 Billion KRW ≈ $19.82 Million USD

Based on the latest financial reports, Biotoxtech Co. Ltd (086040) has net assets worth ₩29.25 Billion KRW (≈ $19.82 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩130.06 Billion ≈ $88.14 Million USD) and total liabilities (₩100.81 Billion ≈ $68.32 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 086040 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩29.25 Billion
% of Total Assets	22.49%
Annual Growth Rate	2.78%
5-Year Change	-22.39%
10-Year Change	30.12%
Growth Volatility	12.61

Biotoxtech Co. Ltd - Net Assets Trend (2011–2025)

This chart illustrates how Biotoxtech Co. Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market value of Biotoxtech Co. Ltd.

Annual Net Assets for Biotoxtech Co. Ltd (2011–2025)

The table below shows the annual net assets of Biotoxtech Co. Ltd from 2011 to 2025. Also explore Biotoxtech Co. Ltd (086040) net asset momentum to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	₩31.93 Billion ≈ $21.64 Million	-20.34%
2024-12-31	₩40.08 Billion ≈ $27.16 Million	-16.90%
2023-12-31	₩48.23 Billion ≈ $32.69 Million	+9.04%
2022-12-31	₩44.23 Billion ≈ $29.98 Million	+7.51%
2021-12-31	₩41.14 Billion ≈ $27.88 Million	+22.72%
2020-12-31	₩33.53 Billion ≈ $22.72 Million	+11.04%
2019-12-31	₩30.19 Billion ≈ $20.46 Million	-3.40%
2018-12-31	₩31.25 Billion ≈ $21.18 Million	+17.54%
2017-12-31	₩26.59 Billion ≈ $18.02 Million	+8.35%
2016-12-31	₩24.54 Billion ≈ $16.63 Million	+4.06%
2015-12-31	₩23.58 Billion ≈ $15.98 Million	-11.62%
2014-12-31	₩26.68 Billion ≈ $18.08 Million	+4.23%
2013-12-31	₩25.60 Billion ≈ $17.35 Million	-1.26%
2012-12-31	₩25.93 Billion ≈ $17.57 Million	+19.25%
2011-12-31	₩21.74 Billion ≈ $14.73 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Biotoxtech Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 116051021000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩1.16 Billion	2.89%
Other Components	₩39.00 Billion	97.11%
Total Equity	₩40.16 Billion	100.00%

Biotoxtech Co. Ltd Competitors by Market Cap

The table below lists competitors of Biotoxtech Co. Ltd ranked by their market capitalization.

Company	Market Cap
Jiyuan Packaging Holdings Ltd TW:8488	$22.74 Million
JV SPAC Acquisition Corp. Class A Ordinary Share NASDAQ:JVSA	$22.75 Million
Orient Precision Industries Inc KQ:065500	$22.75 Million
Allied Gaming & Entertainment Inc. NASDAQ:AGAE	$22.76 Million
AVOD Kurutulmus Gida ve Tarim Urunleri Sanayi Ticaret AS IS:AVOD	$22.74 Million
Studio Mir Co. Ltd. KQ:408900	$22.74 Million
Country Club Hospitality & Holidays Limited NSE:CCHHL	$22.73 Million
ARENA.PL S.A. ZY -50 F:8G6	$22.72 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Biotoxtech Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 40,082,120,000 to 40,157,348,460, a change of 75,228,460 (0.2%).
Net income of 1,162,772,800 contributed positively to equity growth.
Share repurchases of 998,007,450 reduced equity.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩1.16 Billion	+2.9%
Share Repurchases	₩998.01 Million	-2.49%
Other Changes	₩-89.54 Million	-0.22%
Total Change	₩-	0.19%

Book Value vs Market Value Analysis

This analysis compares Biotoxtech Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.88x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.35x to 0.88x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩1705.53	₩2305.00	x
2017-12-31	₩1836.93	₩2305.00	x
2018-12-31	₩2150.46	₩2305.00	x
2019-12-31	₩2074.08	₩2305.00	x
2020-12-31	₩2297.16	₩2305.00	x
2021-12-31	₩2811.05	₩2305.00	x
2022-12-31	₩3022.25	₩2305.00	x
2023-12-31	₩3246.60	₩2305.00	x
2024-12-31	₩2549.63	₩2305.00	x
2025-12-31	₩2606.61	₩2305.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Biotoxtech Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.90%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.47%
• Asset Turnover: 0.36x
• Equity Multiplier: 3.28x
Recent ROE (2.90%) is above the historical average (0.84%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	16.39%	14.18%	0.52x	2.21x	₩1.28 Billion
2012	5.55%	7.63%	0.40x	1.83x	₩-1.09 Billion
2014	-17.44%	-30.01%	0.32x	1.84x	₩-7.12 Billion
2015	-17.22%	-23.42%	0.37x	2.00x	₩-6.17 Billion
2016	4.26%	4.69%	0.46x	1.96x	₩-1.41 Billion
2017	5.23%	5.44%	0.43x	2.25x	₩-1.27 Billion
2018	11.60%	13.30%	0.43x	2.02x	₩498.76 Million
2019	-5.24%	-6.12%	0.43x	1.99x	₩-4.60 Billion
2020	7.80%	9.89%	0.42x	1.90x	₩-738.94 Million
2021	17.29%	21.74%	0.36x	2.21x	₩3.00 Billion
2022	6.16%	7.31%	0.30x	2.84x	₩-1.70 Billion
2023	-9.43%	-14.95%	0.22x	2.84x	₩-10.05 Billion
2024	-16.04%	-15.55%	0.30x	3.40x	₩-10.44 Billion
2025	2.90%	2.47%	0.36x	3.28x	₩-2.85 Billion

Industry Comparison

This section compares Biotoxtech Co. Ltd's net assets metrics with peer companies in the Biotechnology & Medical Research industry.

Industry Context

Industry: Biotechnology & Medical Research
Average net assets among peers: $123,913,133,993
Average return on equity (ROE) among peers: -12.73%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Biotoxtech Co. Ltd (086040)	₩29.25 Billion	16.39%	3.45x	$22.74 Million
Macrogen Inc (038290)	$177.43 Billion	-4.29%	0.86x	$79.73 Million
Panagene Inc (046210)	$16.66 Billion	-24.25%	1.30x	$25.46 Million
Cell Biotech Co. Ltd (049960)	$124.17 Billion	12.18%	0.05x	$80.57 Million
Bioneer Corporation (064550)	$30.61 Billion	-25.57%	1.68x	$137.77 Million
MEDIPOST Co. Ltd (078160)	$252.60 Billion	-24.75%	0.64x	$93.28 Million
Peptron Inc (087010)	$142.01 Billion	-9.73%	0.26x	$1.54 Billion

About Biotoxtech Co. Ltd

KQ:086040 Korea Biotechnology & Medical Research

Market Cap

$22.74 Million

₩33.55 Billion KRW

Market Cap Rank

#24797 Global

#1786 in Korea

Share Price

₩2305.00

Change (1 day)

+0.44%

52-Week Range

₩1983.00 - ₩3925.00

All Time High

₩23000.00